Scinai Immunotherapeutics
Chana Sternberg RN, BSN, M.Occ. H is a highly experienced healthcare professional serving as the Head of Clinical Operations at ImmunoBrain Checkpoint since January 2020. As the founder, owner, and CEO of Chana Sternberg Consultancy, established in May 2008, Chana provides clinical trial services in Israel, managing various studies for clients such as NeuroDerm, Intec Pharma Ltd., Terumo, Entera Bio Ltd., Edwards Lifesciences, Kamada, and BiondVax Pharmaceuticals Ltd. Chana's expertise includes overseeing clinical trial activities, protocol development, and project management, particularly in Parkinson's Disease and ADHD studies. With a solid educational background including a Master's in Occupational Health from Tel Aviv University and a Bachelor's in Nursing from The Hebrew University of Jerusalem, Chana is well-equipped to lead and consult in the field of clinical operations.
This person is not in any teams
This person is not in any offices
Scinai Immunotherapeutics
1 followers
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com